Chembio Diagnostics Inc. (NASDAQ:CEMI) changes shares on Monday trading session, with a change of 16.11% or $1.45 shares. The trading starts at $9.59 and closed at $9.00 throughout the day. The trading session low price was $9.51 and day high was $10.64 on Monday, June 15. After the session, the Healthcare sector daily volume shifted to 1.95 million while its average volume is 1.41M. In other hand, the CEMI market cap reached to $198.97M.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 18.75% and down -16.60% for month. Its quarterly performance was 342.80% above, while its half year performance is up 134.83%. CEMI yearly performance stood at positive 74.17% and rise 129.17% for year-to-date. Current recommendation for Chembio Diagnostics Inc. is 1.40.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. CEMI EPS (TTM) for 12-month is -0.93. EPS for this year is -48.00%, while for the next year its value is 2.43. Its EPS Q/Q reached -77.20%. It has an EPS of -46.60% down for past five years and for the next five years will be up 25.00%.
The insider ownership moved to 0.20% and institutional holding shifted to 41.20%.
The company posted an EPS (TTM) of -0.93. According to the most recent quarter report on (Jun 2020), 5 analysts estimated an average EPS of 0.06, while -0.19 EPS posted a year ago period. Analyst Estimated EPS for CEMI published in the report was -0.21-0.7 during the same period. Comparing with last year, the average estimated EPS was -0.19 which is higher than -0.29 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for CEMI rise 67.03% for period of 200 days. SMA for 50 days was -2.46% which is showing red signal, while SMA-20 was 7.80%. The moving average value for Chembio Diagnostics Inc. (CEMI) is 6.63 and 10.74 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in CEMI stock. On Nov 11, Potthoff John Gary, Director, bought 10,000 trading shares at the cost of $4.44, which valued at 44400.0.